Back
Rocket Pharmaceuticals Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
32
RCKT
Rocket Pharmaceuticals
Last Price:
$2.81
Seasonality Move:
10.35%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight selling pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.67 | Buy |
| 20-day SMA: | 2.81 | Buy |
| 50-day SMA: | 4.7 | Sell |
| 200-day SMA: | 10.57 | Sell |
| 8-day EMA: | 2.73 | Buy |
| 20-day EMA: | 3.01 | Sell |
| 50-day EMA: | 4.3 | Sell |
| 200-day EMA: | 9.89 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 41.69 | Sell |
| Chaikin Money Flow: | -76042 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Rocket Pharmaceuticals Technical Analysis
| Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 2.90 while RCKT 8-day simple moving average is 2.67, which is a Buy signal.
-
The stock price of RCKT is 2.90 while Rocket Pharmaceuticals 20-day SMA is 2.81, which makes it a Buy.
-
Rocket Pharmaceuticals 50-day simple moving average is 4.70 while RCKT share price is 2.90, making it a Sell technically.
-
RCKT stock price is 2.90 and Rocket Pharmaceuticals 200-day simple moving average is 10.57, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
32
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $2.90. The Score for RCKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
312.4M
Price in USD:
2.90
Share Volume:
1.7M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
26.98
52-Week Low:
2.19
Sell
32
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 2.90 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 2.90 while RCKT 8-day exponential moving average is 2.73, which is a Buy signal.
-
The stock price of RCKT is 2.90 while Rocket Pharmaceuticals 20-day EMA is 3.01, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day exponential moving average is 4.30 while RCKT share price is 2.90, making it a Sell technically.
-
RCKT stock price is 2.90 and Rocket Pharmaceuticals 200-day simple moving average is 9.89, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.16 per share, an increase this year of $0.69 per share, and an increase next year of $0.63 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is -0.49, suggesting Rocket Pharmaceuticals is a Sell
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 41.69, which suggest Rocket Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is ( - ), which suggest Rocket Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is ( - ), which suggest Rocket Pharmaceuticals is a Buy
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.